Jordan F Karp1, Mary Amanda Dew2, Abdus S Wahed3, Kelley Fitzgerald4, Chloe A Bolon5, Debra K Weiner6, Jennifer Q Morse7, Steve Albert8, Meryl Butters5, Ariel Gildengers5, Charles F Reynolds9. 1. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA; Veterens Affairs Pittsburgh Health System, Geriatric Research Education and Clinical Center, Pittsburgh, PA. 2. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA; School of Public Health, University of Pittsburgh School of Medicine, Pittsburgh, PA. 3. Department of Biostatistics, University of Pittsburgh School of Medicine, Pittsburgh, PA. 4. Departmentof Physical Therapy, University of Pittsburgh School of Medicine, Pittsburgh, PA. 5. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA. 6. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA; Department of Medicine, University of Pittsburgh, Pittsburgh, PA; Veterens Affairs Pittsburgh Health System, Geriatric Research Education and Clinical Center, Pittsburgh, PA. 7. Department of Psychology, Chatham University, Pittsburgh, PA. 8. School of Public Health, University of Pittsburgh School of Medicine, Pittsburgh, PA. 9. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA. Electronic address: reynoldscf@upmc.edu.
Abstract
OBJECTIVE: To describe the methodology, challenges, and baseline characteristics of a prevention development trial entitled "Reducing Pain, Preventing Depression." METHODS: A sequential multiple assignment randomized trial (SMART) compared sequences of cognitive behavioral therapy (CBT) and physical therapy for knee pain and prevention of depression and anxiety. Participants were randomized to CBT, physical therapy, or enhanced usual care and followed for 12 months for new-episode depression or anxiety. Participants were age ≥ 60 with knee osteoarthritis and subsyndromal depression, defined as 9-item Patient Health Questionnaire (PHQ-9) score ≥1 (which included the endorsement of one of the cardinal symptoms of depression [low mood or anhedonia]) and no diagnosis of major depressive disorder per the Structured Clinical Interview for DSM-IV. Depression and anxiety severity and characterization of new episodes were assessed with the PHQ-9, Generalized Anxiety Disorder-7, and the PRIME-MD. Knee pain was characterized with the Western Ontario McMaster Arthritis Index. Response was defined as at least "Very Much Better" on a Patient Global Impression of Change. RESULTS: At baseline there were 99 patients with an average age of 71; 61.62% were women and 81.8% white. The average PHQ-9 was 5.6 and average Generalized Anxiety Disorder-7, was 3.2. Most were satisfied with the interventions and study procedures. The challenges and solutions described here will also be used in a confirmatory clinical trial of efficacy. CONCLUSION: A SMART design for depression and anxiety prevention, using both CBT and physical therapy, appears to be feasible and acceptable to participants. The methodologic innovations of this project may advance the field of late-life depression and anxiety prevention.
RCT Entities:
OBJECTIVE: To describe the methodology, challenges, and baseline characteristics of a prevention development trial entitled "Reducing Pain, Preventing Depression." METHODS: A sequential multiple assignment randomized trial (SMART) compared sequences of cognitive behavioral therapy (CBT) and physical therapy for knee pain and prevention of depression and anxiety. Participants were randomized to CBT, physical therapy, or enhanced usual care and followed for 12 months for new-episode depression or anxiety. Participants were age ≥ 60 with knee osteoarthritis and subsyndromal depression, defined as 9-item Patient Health Questionnaire (PHQ-9) score ≥1 (which included the endorsement of one of the cardinal symptoms of depression [low mood or anhedonia]) and no diagnosis of major depressive disorder per the Structured Clinical Interview for DSM-IV. Depression and anxiety severity and characterization of new episodes were assessed with the PHQ-9, Generalized Anxiety Disorder-7, and the PRIME-MD. Knee pain was characterized with the Western Ontario McMaster Arthritis Index. Response was defined as at least "Very Much Better" on a Patient Global Impression of Change. RESULTS: At baseline there were 99 patients with an average age of 71; 61.62% were women and 81.8% white. The average PHQ-9 was 5.6 and average Generalized Anxiety Disorder-7, was 3.2. Most were satisfied with the interventions and study procedures. The challenges and solutions described here will also be used in a confirmatory clinical trial of efficacy. CONCLUSION: A SMART design for depression and anxiety prevention, using both CBT and physical therapy, appears to be feasible and acceptable to participants. The methodologic innovations of this project may advance the field of late-life depression and anxiety prevention.
Authors: Kim van Zoonen; Claudia Buntrock; David Daniel Ebert; Filip Smit; Charles F Reynolds; Aartjan T F Beekman; Pim Cuijpers Journal: Int J Epidemiol Date: 2014-04 Impact factor: 7.196
Authors: Jürgen Unützer; Wayne Katon; Christopher M Callahan; John W Williams; Enid Hunkeler; Linda Harpole; Marc Hoffing; Richard D Della Penna; Polly Hitchcock Noël; Elizabeth H B Lin; Patricia A Areán; Mark T Hegel; Lingqi Tang; Thomas R Belin; Sabine Oishi; Christopher Langston Journal: JAMA Date: 2002-12-11 Impact factor: 56.272
Authors: Bruce A Arnow; Enid M Hunkeler; Christine M Blasey; Janelle Lee; Michael J Constantino; Bruce Fireman; Helena C Kraemer; Robin Dea; Rebecca Robinson; Chris Hayward Journal: Psychosom Med Date: 2006 Mar-Apr Impact factor: 4.312
Authors: Chao-Yi Wu; Juleen Rodakowski; Lauren Terhorst; Mary Amanda Dew; Meryl Butters; Jordan F Karp; Steven M Albert; Ariel G Gildengers; Charles F Reynolds; Elizabeth R Skidmore Journal: J Appl Gerontol Date: 2021-01-06
Authors: Jordan F Karp; Jun Zhang; Abdus S Wahed; Stewart Anderson; Mary Amanda Dew; G Kelley Fitzgerald; Debra K Weiner; Steve Albert; Ari Gildengers; Meryl Butters; Charles F Reynolds Journal: Am J Geriatr Psychiatry Date: 2019-03-21 Impact factor: 4.105
Authors: Z Butt; M A Dew; Q Liu; M A Simpson; A R Smith; J Zee; B W Gillespie; S E Abbey; D P Ladner; R Weinrieb; R A Fisher; S Hafliger; N Terrault; J Burton; A H Sherker; A DiMartini Journal: Am J Transplant Date: 2017-01-03 Impact factor: 8.086
Authors: Sarah T Stahl; Helene M Altmann; Mary Amanda Dew; Steven M Albert; Meryl Butters; Ariel Gildengers; Charles F Reynolds; Jordan F Karp Journal: J Am Geriatr Soc Date: 2021-01-02 Impact factor: 5.562